An Open Label, Randomised, Single Dose, 3-period Crossover Study in Healthy Volunteers to: a) Compare the Pharmacokinetics of Chronocort® Formulations Versus Immediate Release Hydrocortisone, and (b) Determine the Dose Proportionality of Chronocort® Formulations
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Adrenal insufficiency; Congenital adrenal hyperplasia
- Focus Pharmacokinetics
- Sponsors Diurnal
- 16 Jan 2017 New trial record